Clinical trials of antibody therapy, Immunology Today, vol.21, issue.8, pp.403-410, 2000. ,
DOI : 10.1016/S0167-5699(00)01669-8
Therapeutic antibodies: Magic bullets hit the target, Nature, vol.14, issue.6889, pp.584-586, 2002. ,
DOI : 10.1073/PNAS.98.4.1799
Monoclonal antibodybased immunotherapies, Current gene therapy, 2004. ,
Secretion of Cloned Antibodies by Genetically Modified Myogenic Cells, Human Gene Therapy, vol.8, issue.10, pp.1219-1229, 1997. ,
DOI : 10.1089/hum.1997.8.10-1219
Sustained Systemic Delivery of Monoclonal Antibodies by Genetically Modified Skin Fibroblasts, Journal of Investigative Dermatology, vol.115, issue.4, pp.740-745, 2000. ,
DOI : 10.1046/j.1523-1747.2000.00106.x
Skin as a Potential Organ for Ectopic Monoclonal Antibody Production11The authors declared not to have a conflict of interest., Journal of Investigative Dermatology, vol.118, issue.2, pp.288-294, 2002. ,
DOI : 10.1046/j.0022-202x.2001.01625.x
Production of a Model Monoclonal Antibody on Adenoviral Gene Transfer, Human Gene Therapy, vol.13, issue.12, pp.1483-1493, 2002. ,
DOI : 10.1089/10430340260185111
Generation of Neutralizing Activity against Human Immunodeficiency Virus Type 1 in Serum by Antibody Gene Transfer, Journal of Virology, vol.76, issue.17, pp.8769-8775, 2002. ,
DOI : 10.1128/JVI.76.17.8769-8775.2002
Systemic long-term delivery of antibodies in immunocompetent animals using cellulose sulphate capsules containing antibody-producing cells, Gene Therapy, vol.5, issue.6, pp.828-834, 1998. ,
DOI : 10.1038/sj.gt.3300632
Production of Therapeutic Monoclonal Antibodies, Human Gene Therapy, vol.11, issue.10, pp.1407-1415, 2000. ,
DOI : 10.1089/10430340050057486
The Hepatitis C Virus (HCV)???Trimera Mouse: A Model for Evaluation of Agents against HCV, The Journal of Infectious Diseases, vol.185, issue.2, pp.153-161, 2002. ,
DOI : 10.1086/338266
Antiviral activity of the neutralizing antibodies 2F5 and 2G12 in asymptomatic HIV-1-infected humans, AIDS, vol.16, issue.15, pp.2019-2025, 2002. ,
DOI : 10.1097/00002030-200210180-00006
Gene transfer into muscle by electroporation in vivo, Nature Biotechnology, vol.3, issue.9, pp.867-870, 1998. ,
DOI : 10.1016/0378-1119(91)90434-D
High-efficiency gene transfer into skeletal muscle mediated by electric pulses, Proceedings of the National Academy of Sciences, vol.63, issue.5, pp.4262-4267, 1999. ,
DOI : 10.1016/S0006-3495(92)81709-5
In vivo plasmid DNA electrotransfer, Current Opinion in Biotechnology, vol.13, issue.5, pp.443-447, 2002. ,
DOI : 10.1016/S0958-1669(02)00377-4
Towards non-viral gene therapy], Bull Acad Natl Med, vol.185, pp.1683-1697, 2001. ,
Electrically induced DNA uptake by cells is a fast process involving DNA electrophoresis, Biophysical Journal, vol.60, issue.4, pp.804-811, 1991. ,
DOI : 10.1016/S0006-3495(91)82115-4
Importance of association between permeabilization and electrophoretic forces for intramuscular DNA electrotransfer, Biochimica et Biophysica Acta (BBA) - General Subjects, vol.1474, issue.3, pp.353-359, 2000. ,
DOI : 10.1016/S0304-4165(00)00028-3
Direct visualization at the single-cell level of electrically mediated gene delivery, Proceedings of the National Academy of Sciences, vol.70, issue.3, pp.1292-1297, 2002. ,
DOI : 10.1016/S0009-3084(99)00060-2
Analysis of the individual contributions of immunoglobulin heavy and light chains to the binding of antigen using cell transfection and plasmon resonance analysis, Journal of Immunological Methods, vol.193, issue.2, pp.177-187, 1996. ,
DOI : 10.1016/0022-1759(96)00043-9
pCOR: a new design of plasmid vectors for nonviral gene therapy, Gene Therapy, vol.6, issue.8, pp.1482-1488, 1999. ,
DOI : 10.1038/sj.gt.3300968
Studying Gene Function in Eukaryotes by Conditional Gene Inactivation, Annual Review of Genetics, vol.36, issue.1, pp.153-173, 2002. ,
DOI : 10.1146/annurev.genet.36.041002.120114
Tight control of gene expression in mammalian cells by tetracycline-responsive promoters., Proceedings of the National Academy of Sciences, vol.89, issue.12, pp.5547-5551, 1992. ,
DOI : 10.1073/pnas.89.12.5547
DNA vaccines: improving expression of antigens, Genet Vaccines Ther, vol.1, issue.2, 2003. ,
Plasmid DNA electrotransfer for intracellular and secreted proteins expression: new methodological developments and applications, The Journal of Gene Medicine, vol.6, issue.S1, pp.11-23, 2004. ,
DOI : 10.1002/jgm.508
Reactivation of the previously silenced cytomegalovirus major immediate-early promoter in the mouse liver: involvement of NFkappaB, J Virol, vol.72, pp.180-190, 1998. ,
Long-term expression of a fluorescent reporter gene via direct injection of plasmid vector into mouse skeletal muscle: Comparison of human creatine kinase and CMV promoter expression levels in vivo, Cell Transplantation, vol.5, issue.3, pp.411-419, 1996. ,
DOI : 10.1016/0963-6897(95)02026-8
Muscle-Specific Expression of Hepatitis B Surface Antigen: No Effect on DNA-Raised Immune Responses, Virology, vol.260, issue.1, pp.74-83, 1999. ,
DOI : 10.1006/viro.1999.9795
Synthetic muscle promoters: activities exceeding naturally occurring regulatory sequences, Nat Biotechnol, vol.17, pp.241-245, 1999. ,
Lack of an Immune Response against the Tetracycline-Dependent Transactivator Correlates with Long-Term Doxycycline-Regulated Transgene Expression in Nonhuman Primates after Intramuscular Injection of Recombinant Adeno-Associated Virus, Journal of Virology, vol.76, issue.22, pp.11605-11611, 2002. ,
DOI : 10.1128/JVI.76.22.11605-11611.2002
Long-term control of erythropoietin secretion by doxycycline in mice transplanted with engineered primary myoblasts, Nature Medicine, vol.70, issue.3, pp.299-305, 1997. ,
DOI : 10.1016/0092-8674(81)90343-3
Modulation of Erythropoietin Delivery from Engineered Muscles in Mice, Human Gene Therapy, vol.8, issue.2, pp.195-204, 1997. ,
DOI : 10.1089/hum.1997.8.2-195
Control of erythropoietin delivery by doxycycline in mice after intramuscular injection of adeno-associated vector, Blood, vol.92, pp.1512-1517, 1998. ,